Stocks and securities in focus
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Corbus Pharmaceuticals Holding Inc. | -2.060% | 1.658% | 4.061% | 61.981% | 22.643% | 6575.739% | -80.127% |
| Pfizer Inc. | 1.260% | -0.667% | -0.130% | 19.405% | 8.553% | -38.400% | -28.194% |
| Sangamo Therapeutics Inc. | 0.680% | 1.388% | -29.790% | -61.259% | -33.162% | -84.467% | -97.559% |
| Viking Therapeutics Inc | -0.660% | 1.005% | -3.613% | 45.547% | -3.334% | 76.729% | 514.804% |
| Fresenius Medical Care AG & Co KGaA ST | 2.160% | -3.578% | -2.951% | -11.088% | -4.784% | -8.381% | -38.805% |
| Heron Therapeutics Inc. | 1.880% | 12.739% | 1.659% | -50.864% | -28.501% | -67.883% | -94.618% |
| Fresenius SE & Co. KGaA | 0.290% | -0.314% | -5.554% | 12.926% | -9.243% | 71.683% | 15.288% |
| Implanet S.A. | 0.450% | 3.505% | 9.113% | 158.762% | 14.767% | 47.078% | -78.985% |
| QIAGEN NV | -0.150% | - | - | - | - | - | - |
| Travere Therapeutics Inc. | -1.190% | 24.444% | 37.705% | 162.500% | 1.205% | - | - |
| Ultragenyx Pharmaceutical Inc. | 0.240% | 3.922% | 12.169% | -29.801% | 26.190% | -38.372% | -76.831% |